
|Articles|July 28, 2021
Supplements and Featured Publications
- Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease
Outcomes-Based Agreements Give New Insight for Treatment of Diabetes and Cardiovascular Disease
Advertisement
This AJMC® Profiles in Care provides an in-depth look into the results of the innovative outcomes-based agreement between Boehringer Ingelheim and Highmark Inc that focused on total cost of care for patients with type 2 diabetes and cardiovascular disease. An overview of the results, as well as valuable insights from experts from Boehringer Ingelheim and Highmark, are included.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
J&J Agreement Brings 15 of 17 Pharma Companies Into Trump's Drug-Pricing Effort
2
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
3
Insights Into Patient Portal Engagement Leveraging Observational Electronic Health Data
4
Postpandemic Nursing Home Capacity Declines Tied to Longer Hospital Stays, Increased Patient Travel
5





























































